|
|||||
|
|
Triazolyl Azabicyclo[3.1.0]hexanes: a Class of Potent and Selective Dopamine D3 Receptor Antagonists |
|
| Authors: | Giorgio Bonanomi Dr. Simone Braggio Dr. Anna Maria Capelli Dr. Anna Checchia Dr. Romano Di Fabio Dr. Carla Marchioro Dr. Luca Tarsi Dr. Giovanna Tedesco Dr. Silvia Terreni Dr. Angela Worby Dr. Christian Heibreder Dr. Fabrizio Micheli Dr. |
| Affiliation: | 1. Neurosciences Centre of Excellence, GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona (Italy), Fax: (+39)?045‐8218196;2. Molecular Discovery Research, GlaxoSmithKline Medicines Research Centre, Via Fleming 4, 37135 Verona (Italy);3. Molecular Discovery Research, GlaxoSmithKline, NFSP, Harlow (UK);4. Reckitt Benckiser Pharmaceuticals, Richmond VA 23235 (USA) |
| Abstract: | |
| Keywords: | azabicyclo[3.1.0]hexanes dopamine D3 antagonists hERG channel receptors |